Ebrahim, Adzmier A.

HRN: 23-44-52  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/27/2023
AMPICILLIN 250MG (VIAL)
07/27/2023
08/03/2023
IV
95mg
Q12
Potential Septic Newborn
Checking Final Appropriateness 
07/27/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/27/2023
08/03/2023
IV
30mg
Q24h
Potential Septic Newborn
Checking Final Appropriateness 
07/28/2023
CEFTAZIDIME 1GM (VIAL)
07/28/2023
08/04/2023
IV INFUSION FOR 30 MINS
60mg
Q12
PSNB ARDS
Checking Final Appropriateness 
07/31/2023
AMPICILLIN 250MG (VIAL)
07/31/2023
08/07/2023
IV
95mg
BID
Neonatal Pneumonia
Checking Final Appropriateness 
08/02/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
08/02/2023
08/08/2023
IV
190mg
Q12
Neonatal Pneumonia
Checking Final Appropriateness 
08/13/2023
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
08/13/2023
08/26/2023
IVT
40 Mg Ld Then 12 Mg Md
OD
Sepsis
Checking Final Appropriateness 
08/20/2023
CIPROFLOXACIN 500MG (TAB)
08/20/2023
08/26/2023
PO
30mg
OD
Neonatal Sepsis
Waiting Final Action 
08/20/2023
CIPROFLOXACIN 500MG (TAB)
08/20/2023
08/26/2023
PO VIA NGT
30mg Pptab
BID
Neonatal Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: